In addition to the ability to provide accurate pulse oximetry (SpO2) readings in situations of motion and low perfusion, Masimo Rainbow SET now allows clinicians to continuously and noninvasively monitor the level of carboxyhemoglobin (SpCO) and methemoglobin (SpMet) in the blood, helping them detect and treat potentially life-threatening conditions earlier than before.
The new extensions to the platform include the availability of a bedside monitor, the Radical-7, which can either be ordered with the ability to monitor SpCO and SpMet direct from the factory or can be upgraded in the field with the purchase of optional software enhancements at a later date. Additionally, the company is introducing a full line of single-patient adhesive sensors to be able to deliver these enhanced parameters. The new line will include adult, pediatric, infant and neonatal sensors, as well as a 10-foot cable.
Carboxyhemoglobin and methemoglobin are both dysfunctional forms of hemoglobin that are incapable of transporting oxygen, thus reducing blood oxygenation and potentially inducing tissue hypoxemia.